Related Experiment Video
Updated: May 5, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis
Alexandre M Benjo1, Georges E El-Hayek, Franz Messerli
1St. Luke's and Roosevelt Hospitals and Columbia University, College of Physicians and Surgeons, New York, New York; Ochsner Medical Center, New Orleans, Louisiana.
Insights
High-dose statin loading before percutaneous coronary intervention (PCI) significantly reduces peri-procedural myocardial infarction (pMI) and clinical events, especially in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS). This strategy offers a key benefit for cardiac patients undergoing PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pharmacology
Background:
- Statin therapy is crucial for managing cardiovascular disease.
- Pre-procedural statin loading before percutaneous coronary intervention (PCI) is known to decrease peri-procedural myocardial infarction (pMI).
- The broader clinical benefits of pre-procedural statin loading require further investigation.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials (RCTs) evaluating statin loading prior to PCI.
- To assess the impact of pre-procedural statin loading on pMI and major adverse cardiac events.
Main Methods:
- A systematic search for RCTs involving statin-naive patients undergoing PCI for stable angina or NSTE-ACS.
- Inclusion criteria focused on statin administration before PCI.
- Evaluation of pMI incidence and major cardiac events, including spontaneous MI, death, and target vessel revascularization.
Main Results:
- 14 RCTs with 3,146 patients were included.
- Statin loading before PCI showed a 56% relative reduction in pMI (OR: 0.44).
- A 41% reduction in clinical events was observed with pre-procedural statin loading (OR: 0.59), particularly significant in NSTE-ACS patients (OR: 0.18).
Conclusions:
- High-dose statin therapy prior to PCI significantly reduces pMI and short-term clinical events in NSTE-ACS patients.
- Pre-procedural statin loading is a beneficial strategy for selected cardiac patients undergoing PCI.
- The findings support the use of statin loading in specific patient populations to improve procedural outcomes.
Objective:
We performed a meta-analysis of randomized controlled trials of statin loading prior to percutaneous coronary intervention (PCI).
Background:
Statin loading prior to PCI has been shown to decrease peri-procedural myocardial infarction (pMI) but less is known regarding the clinical benefit of pre-procedural statin loading.
Methods:
We searched for trials of statin naïve patients presenting with stable angina or NSTE-ACS and treated with statins prior to PCI. We evaluated the incidence of pMI and major cardiac events including spontaneous myocardial infarction, death, and target vessel revascularization.
Results:
Out of 1,210 articles, 14 randomized controlled trials were included in this meta-analysis. Among 3,146 patients, 1,591 patients were randomized to a loading dose of statin before PCI and 1,555 patients were given statin therapy initiated only after the PCI. Statin loading prior to PCI was associated with a 56% relative reduction in pMI (OR: 0.44, 95% CI: 0.35-0.56; P < 0.00001). There was a 41% reduction in clinical events in follow-up in the group of patients treated with statin loading prior to PCI (OR: 0.59, 95% CI: 0.38-0.92, P = 0.02). When stratified according to the clinical presentation, the results were only significant for those patients with NSTE-ACS (OR: 0.18, 95% CI: 0.07-0.47; P = 0.0005) and was not noted in the group of patients who underwent PCI for stable angina (OR: 0.92, 95% CI: 0.53-1.61; P = 0.78).
Conclusions:
High dose statin therapy given prior to PCI in patients with NSTE-ACS is associated with a reduction in pMI and short-term clinical events. © 2013 Wiley Periodicals, Inc.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:26Atherosclerosis III: Management
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:27Coronary Artery Disease V: Interprofessional Care
01:26Coronary Artery Disease IV: Preventive Measures
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management